Fine-tuning the spike: role of the nature and topology of the glycan shield in the structure and dynamics of the SARS-CoV-2 S
- PMID: 35126971
- PMCID: PMC8729800
- DOI: 10.1039/d1sc04832e
Fine-tuning the spike: role of the nature and topology of the glycan shield in the structure and dynamics of the SARS-CoV-2 S
Abstract
The dense glycan shield is an essential feature of the SARS-CoV-2 spike (S) architecture, key to immune evasion and to the activation of the prefusion conformation. Recent studies indicate that the occupancy and structures of the SARS-CoV-2 S glycans depend not only on the nature of the host cell, but also on the structural stability of the trimer; a point that raises important questions about the relative competence of different glycoforms. Moreover, the functional role of the glycan shield in the SARS-CoV-2 pathogenesis suggests that the evolution of the sites of glycosylation is potentially intertwined with the evolution of the protein sequence to affect optimal activity. Our results from multi-microsecond molecular dynamics simulations indicate that the type of glycosylation at N234, N165 and N343 greatly affects the stability of the receptor binding domain (RBD) open conformation, and thus its exposure and accessibility. Furthermore, our results suggest that the loss of glycosylation at N370, a newly acquired modification in the SARS-CoV-2 S glycan shield's topology, may have contributed to increase the SARS-CoV-2 infectivity as we find that N-glycosylation at N370 stabilizes the closed RBD conformation by binding a specific cleft on the RBD surface. We discuss how the absence of the N370 glycan in the SARS-CoV-2 S frees the RBD glycan binding cleft, which becomes available to bind cell-surface glycans, and potentially increases host cell surface localization.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
There are no conflicts to declare.
Figures
Similar articles
-
Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern.Elife. 2024 Jun 12;13:RP95708. doi: 10.7554/eLife.95708. Elife. 2024. PMID: 38864493 Free PMC article.
-
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein.ACS Cent Sci. 2020 Oct 28;6(10):1722-1734. doi: 10.1021/acscentsci.0c01056. Epub 2020 Sep 23. ACS Cent Sci. 2020. PMID: 33140034 Free PMC article.
-
Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein.bioRxiv [Preprint]. 2020 Sep 4:2020.06.11.146522. doi: 10.1101/2020.06.11.146522. bioRxiv. 2020. Update in: ACS Cent Sci. 2020 Oct 28;6(10):1722-1734. doi: 10.1021/acscentsci.0c01056 PMID: 32577644 Free PMC article. Updated. Preprint.
-
Exploring the Potential of Chemical Inhibitors for Targeting Post-translational Glycosylation of Coronavirus (SARS-CoV-2).ACS Omega. 2022 Jul 28;7(31):27038-27051. doi: 10.1021/acsomega.2c02345. eCollection 2022 Aug 9. ACS Omega. 2022. PMID: 35937682 Free PMC article. Review.
-
[Glycosylation, glycan receptors recognition of SARS-CoV-2 and discoveries of glycan inhibitors against SARS-CoV-2].Sheng Wu Gong Cheng Xue Bao. 2022 Sep 25;38(9):3157-3172. doi: 10.13345/j.cjb.220175. Sheng Wu Gong Cheng Xue Bao. 2022. PMID: 36151791 Review. Chinese.
Cited by
-
SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact.Commun Biol. 2022 Nov 3;5(1):1170. doi: 10.1038/s42003-022-04138-6. Commun Biol. 2022. PMID: 36329138 Free PMC article.
-
The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming.Proc Natl Acad Sci U S A. 2024 Oct 22;121(43):e2404892121. doi: 10.1073/pnas.2404892121. Epub 2024 Oct 14. Proc Natl Acad Sci U S A. 2024. PMID: 39401361
-
Molecular dynamics studies reveal structural and functional features of the SARS-CoV-2 spike protein.Bioessays. 2022 Sep;44(9):e2200060. doi: 10.1002/bies.202200060. Epub 2022 Jul 17. Bioessays. 2022. PMID: 35843871 Free PMC article. Review.
-
Analysis of Viral Spike Protein N-Glycosylation Using Ultraviolet Photodissociation Mass Spectrometry.Anal Chem. 2022 Apr 19;94(15):5776-5784. doi: 10.1021/acs.analchem.1c04874. Epub 2022 Apr 7. Anal Chem. 2022. PMID: 35388686 Free PMC article.
-
Shooting at a Moving Target-Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development.Vaccines (Basel). 2021 Sep 22;9(10):1052. doi: 10.3390/vaccines9101052. Vaccines (Basel). 2021. PMID: 34696160 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
